Patents Assigned to Bioventrix, Inc.
-
Patent number: 10206779Abstract: A heart implant alignment and delivery device includes an elongate body having an opening that is disposed near a distal end of the elongate body. The opening is configured so that a heart implant is positionable within the opening with the heart implant exposed to a surrounding environment and so that the heart implant is substantially aligned with the distal end of the elongate body. The device also includes an implant reposition member, such as a cable, that is releasably coupleable with the heart implant and that is operationally coupled with the elongate body so that a first operation of the implant reposition member causes the heart implant to be retractably deployed from the opening of the elongate body. The first operation of the implant reposition member may be effected via a handle mechanism that is attached to a proximal end of the elongate body.Type: GrantFiled: September 8, 2016Date of Patent: February 19, 2019Assignee: BioVentrix, Inc.Inventors: Kevin Van Bladel, Meir Moshe, Michael S. Dana
-
Patent number: 10179049Abstract: Embodiments described herein include devices, systems, and methods for reducing the distance between two locations in tissue. In one embodiment, an anchor may reside within the right ventricle in engagement with the septum. A tension member may extend from that anchor through the septum and an exterior wall of the left ventricle to a second anchor disposed along a surface of the heart. Perforating the exterior wall and the septum from an epicardial approach can provide control over the reshaping of the ventricular chamber. Guiding deployment of the implant from along the epicardial access path and another access path into and through the right ventricle provides control over the movement of the anchor within the ventricle. The joined epicardial pathway and right atrial pathway allows the tension member to be advanced into the heart through the right atrium and pulled into engagement along the epicardial access path.Type: GrantFiled: April 24, 2017Date of Patent: January 15, 2019Assignee: BioVentrix, Inc.Inventors: Kevin Van Bladel, Lon Annest, Murray Sheldon, Ernie Heflin, Andrew Wechsler, John Stiggelbout, Rovil Arcia, John Bower
-
Publication number: 20180318084Abstract: Apparatus and methods to reduce ventricular volume are disclosed. The device takes the form of a transventricular anchor, which presses a portion of the ventricular wall inward, thereby reducing the available volume of the ventricle. The anchor is deployed using a curved introducer that may be inserted into one ventricle, through the septum and into the opposite ventricle. Barbs or protrusions along the anchor body combined with a mechanical stop and a sealing member hold the device in place once deployed.Type: ApplicationFiled: July 16, 2018Publication date: November 8, 2018Applicant: BioVentrix, Inc.Inventors: Sing-Fatt Chin, Lon S. Annest
-
Patent number: 10022226Abstract: Apparatus and methods to reduce ventricular volume are disclosed. The device takes the form of a transventricular anchor, which presses a portion of the ventricular wall inward, thereby reducing the available volume of the ventricle. The anchor is deployed using a curved introducer that may be inserted into one ventricle, through the septum and into the opposite ventricle. Barbs or protrusions along the anchor body combined with a mechanical stop and a sealing member hold the device in place once deployed.Type: GrantFiled: March 23, 2015Date of Patent: July 17, 2018Assignee: BioVentrix, Inc.Inventors: Sing-Fatt Chin, Lon S. Annest
-
Publication number: 20180193148Abstract: Devices, systems, and methods for treating a heart of a patient may make use of structures which limit a size of a chamber of the heart, such as by deploying one or more tensile member to bring a wall of the heart and a septum of the heart into contact. A plurality of tension members may help exclude scar tissue and provide a more effective remaining ventricle chamber. The implant may be deployed during beating of the heart, often in a minimally invasive or less-invasive manner. Trauma to the tissues of the heart may be inhibited by selectively approximating tissues while a pressure within the heart is temporarily reduced. Three-dimensional implant locating devices and systems facilitate beneficial heart chamber volumetric shape remodeling.Type: ApplicationFiled: March 9, 2018Publication date: July 12, 2018Applicant: BioVentrix, Inc.Inventors: Lon S. Annest, Arthur A. Bertolero, David K. Swanson
-
Patent number: 9937043Abstract: Embodiments described herein provide devices, systems, and methods that reduce the distance between two locations in tissue, often for treatment of congestive heart failure. For example, an anchor of an implant system may, when the implant system is fully deployed, reside within the right ventricle in engagement with the ventricular septum. The anchor may be deployed into the heart through a working lumen of a minimally invasive access tool. The minimally invasive access tool may have a plurality of grippers near a distal end of the working lumen. The grippers may engage epicardial tissue of the heart and may be moved radially inwardly relative so as to provide stabilization of the epicardial tissue and/or hemostasis near an access site where the anchor is inserted through the epicardium. The minimally invasive access tool may minimize blood loss from the access site and improve anchor implant processes.Type: GrantFiled: July 31, 2015Date of Patent: April 10, 2018Assignee: BioVentrix, Inc.Inventors: Kevin Van Bladel, Lon Annest, John Stiggelbout, Rovil Arcia
-
Publication number: 20180071100Abstract: Devices, systems, and methods for treating a heart of a patient may make use of one or more implant structures which limit a size of a chamber of the heart, such as by deploying a tensile member to bring a wall of the heart toward (optionally into contact with) a septum of the heart.Type: ApplicationFiled: August 28, 2017Publication date: March 15, 2018Applicant: BioVentrix, Inc.Inventors: Lon S. Annest, Arthur A. Bertolero, Sing-Fatt Chin, David K. Swanson
-
Patent number: 9913719Abstract: Devices, systems, and methods for treating a heart of a patient may make use of structures which limit a size of a chamber of the heart, such as by deploying one or more tensile member to bring a wall of the heart and a septum of the heart into contact. A plurality of tension members may help exclude scar tissue and provide a more effective remaining ventricle chamber. The implant may be deployed during beating of the heart, often in a minimally invasive or less-invasive manner. Trauma to the tissues of the heart may be inhibited by selectively approximating tissues while a pressure within the heart is temporarily reduced. Three-dimensional implant locating devices and systems facilitate beneficial heart chamber volumetric shape remodeling.Type: GrantFiled: December 14, 2015Date of Patent: March 13, 2018Assignee: BioVentrix, Inc.Inventors: Lon S. Annest, Arthur A. Bertolero, David K. Swanson
-
Patent number: 9889008Abstract: Medical devices, systems, and methods reduce the distance between two points in tissue, often for treatment of congestive heart failure and often in a minimally invasive manner. An anchor is inserted along an insertion path through a first wall of the heart. An arm of the anchor is deployed and rotationally positioned according to a desired alignment. Application of tension to the anchor may draw the first and second walls of the heart into contact along a desired contour so as to effect a desired change in the geometry of the heart. Additional anchors may be inserted and aligned with the first anchor to close off a portion of a ventricle such that the ventricle is geometrically remodeled and disease progression is reversed, halted, and/or slowed.Type: GrantFiled: November 2, 2016Date of Patent: February 13, 2018Assignee: BioVentrix, Inc.Inventors: Lon S. Annest, Claudio Argento, William Butler, Ernest Heflin
-
Patent number: 9744040Abstract: Devices, systems, and methods for treating a heart of a patient may make use of one or more implant structures which limit a size of a chamber of the heart, such as by deploying a tensile member to bring a wall of the heart toward (optionally into contact with) a septum of the heart.Type: GrantFiled: July 5, 2016Date of Patent: August 29, 2017Assignee: BioVentrix, Inc.Inventors: Lon S. Annest, Arthur A. Bertolero, Sing-Fatt Chin, David K. Swanson
-
Publication number: 20170224490Abstract: Embodiments described herein include devices, systems, and methods for reducing the distance between two locations in tissue. In one embodiment, an anchor may reside within the right ventricle in engagement with the septum. A tension member may extend from that anchor through the septum and an exterior wall of the left ventricle to a second anchor disposed along a surface of the heart. Perforating the exterior wall and the septum from an epicardial approach can provide control over the reshaping of the ventricular chamber. Guiding deployment of the implant from along the epicardial access path and another access path into and through the right ventricle provides control over the movement of the anchor within the ventricle. The joined epicardial pathway and right atrial pathway allows the tension member to be advanced into the heart through the right atrium and pulled into engagement along the epicardial access path.Type: ApplicationFiled: April 24, 2017Publication date: August 10, 2017Applicant: BioVentrix, Inc.Inventors: Kevin Van Bladel, Lon Annest, Murray Sheldon, Ernie Heflin, Andrew Wechsler, John Stiggelbout, Rovil Arcia, John Bower
-
Publication number: 20170216032Abstract: A system for treating a heart includes a catheter that is advanceable into a chamber of the heart and that is repositionable within the chamber between a septal wall and an external wall to enable penetration of the septal and external walls via a needle that is disposed within a lumen of the catheter. A first guidewire is deliverable through the penetration of the septal wall so that a distal end of the first guidewire is disposed within another chamber of the heart. A second guidewire is deliverable through the penetration of the external wall so that a distal end of the second guidewire is disposed externally of the external wall. The first guidewire is connectable to the second guidewire to join or form a path within the chamber that extends between the septal wall and the external wall.Type: ApplicationFiled: January 27, 2017Publication date: August 3, 2017Applicant: BioVentrix, Inc.Inventors: Kevin Van Bladel, Serjan Nikolic, Lon Annest, Rovil Arcia
-
Publication number: 20170165070Abstract: A method for reducing left ventricular volume, which comprises identifying infracted tissue during open chest surgery; reducing left ventricle volume while preserving the ventricular apex; and realigning the ventricular apex, such that the realigning step comprises closing the lower or apical portion of said ventricle to achieve appropriate functional contractile geometry of said ventricle in a dyskinetic ventricle of a heart.Type: ApplicationFiled: December 21, 2016Publication date: June 15, 2017Applicant: BioVentrix, Inc.Inventors: Sing-Fatt Chin, Arthur Bertolero, Lon S. Annest
-
Publication number: 20170156865Abstract: Medical devices, systems, and methods reduce the distance between two points in tissue, often for treatment of congestive heart failure and often in a minimally invasive manner. An anchor is inserted along an insertion path through a first wall of the heart. An arm of the anchor is deployed and rotationally positioned according to a desired alignment. Application of tension to the anchor may draw the first and second walls of the heart into contact along a desired contour so as to effect a desired change in the geometry of the heart. Additional anchors may be inserted and aligned with the first anchor to close off a portion of a ventricle such that the ventricle is geometrically remodeled and disease progression is reversed, halted, and/or slowed.Type: ApplicationFiled: November 2, 2016Publication date: June 8, 2017Applicant: BioVentrix, Inc.Inventors: Lon S. Annest, Claudio Argento, William Butler, Ernest Heflin
-
Patent number: 9662212Abstract: Embodiments described herein include devices, systems, and methods for reducing the distance between two locations in tissue. In one embodiment, an anchor may reside within the right ventricle in engagement with the septum. A tension member may extend from that anchor through the septum and an exterior wall of the left ventricle to a second anchor disposed along a surface of the heart. Perforating the exterior wall and the septum from an epicardial approach can provide control over the reshaping of the ventricular chamber. Guiding deployment of the implant from along the epicardial access path and another access path into and through the right ventricle provides control over the movement of the anchor within the ventricle. The joined epicardial pathway and right atrial pathway allows the tension member to be advanced into the heart through the right atrium and pulled into engagement along the epicardial access path.Type: GrantFiled: April 15, 2016Date of Patent: May 30, 2017Assignee: BioVentrix, Inc.Inventors: Kevin Van Bladel, Lon Annest, Murray Sheldon, Ernie Heflin, Andrew Wechsler, John Stiggelbout, Rovil Arcia, John Bower
-
Publication number: 20170071740Abstract: A heart implant alignment and delivery device includes an elongate body having an opening that is disposed near a distal end of the elongate body. The opening is configured so that a heart implant is positionable within the opening with the heart implant exposed to a surrounding environment and so that the heart implant is substantially aligned with the distal end of the elongate body. The device also includes an implant reposition member, such as a cable, that is releasably coupleable with the heart implant and that is operationally coupled with the elongate body so that a first operation of the implant reposition member causes the heart implant to be retractably deployed from the opening of the elongate body. The first operation of the implant reposition member may be effected via a handle mechanism that is attached to a proximal end of the elongate body.Type: ApplicationFiled: September 8, 2016Publication date: March 16, 2017Applicant: BioVentrix, Inc.Inventors: Kevin Van Bladel, Meir Moshe, Michael S. Dana
-
Patent number: 9526618Abstract: A method for reducing left ventricular volume, which comprises identifying infarcted tissue during open chest surgery; reducing left ventricle volume while preserving the ventricular apex; and realigning the ventricular apex, such that the realigning step comprises closing the lower or apical portion of said ventricle to achieve appropriate functional contractile geometry of said ventricle in a dyskinetic ventricle of a heart.Type: GrantFiled: August 28, 2015Date of Patent: December 27, 2016Assignee: BioVentrix, Inc.Inventors: Sing-Fatt Chin, Arthur Bertolero, Lon S. Annest
-
Publication number: 20160338835Abstract: Embodiments described herein include devices, systems, and methods for reducing the distance between two locations in tissue. In one embodiment, an anchor may reside within the right ventricle in engagement with the septum. A tension member may extend from that anchor through the septum and an exterior wall of the left ventricle to a second anchor disposed along a surface of the heart. Perforating the exterior wall and the septum from an epicardial approach can provide control over the reshaping of the ventricular chamber. Guiding deployment of the implant from along the epicardial access path and another access path into and through the right ventricle provides control over the movement of the anchor within the ventricle. The joined epicardial pathway and right atrial pathway allows the tension member to be advanced into the heart through the right atrium and pulled into engagement along the epicardial access path.Type: ApplicationFiled: April 15, 2016Publication date: November 24, 2016Applicant: BioVentrix, Inc.Inventors: Kevin Van Bladel, Lon Annest, Murray Sheldon, Ernie Heflin, Andrew Wechsler, John Stiggelbout, Rovil Arcia, John Bower
-
Patent number: 9486206Abstract: Medical devices, systems, and methods reduce the distance between two points in tissue, often for treatment of congestive heart failure and often in a minimally invasive manner. An anchor is inserted along an insertion path through a first wall of the heart. An arm of the anchor is deployed and rotationally positioned according to a desired alignment. Application of tension to the anchor may draw the first and second walls of the heart into contact along a desired contour so as to effect a desired change in the geometry of the heart. Additional anchors may be inserted and aligned with the first anchor to close off a portion of a ventricle such that the ventricle is geometrically remodeled and disease progression is reversed, halted, and/or slowed.Type: GrantFiled: March 2, 2015Date of Patent: November 8, 2016Assignee: BioVentrix, Inc.Inventors: Lon S. Annest, Claudio Argento, William Butler, Ernest Heflin
-
Publication number: 20160310276Abstract: Devices, systems, and methods for treating a heart of a patient may make use of one or more implant structures which limit a size of a chamber of the heart, such as by deploying a tensile member to bring a wall of the heart toward (optionally into contact with) a septum of the heart.Type: ApplicationFiled: July 5, 2016Publication date: October 27, 2016Applicant: BioVentrix, Inc.Inventors: Lon S. Annest, Arthur A. Bertolero, Sing-Fatt Chin, David K. Swanson